Drug Information

Drug General Information
Drug ID
D02RXA
Former ID
DNC007585
Drug Name
LVAYPWT
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528976]
Structure
Download
2D MOL

3D MOL
Formula
C43H60N8O10
Canonical SMILES
CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CC1=CC=C(C=C1)O<br />)C(=O)N2CCCC2C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(C(C)O)C<br />(=O)O)N
InChI
1S/C43H60N8O10/c1-22(2)18-30(44)38(55)49-35(23(3)4)41(58)46-24(5)37(54)48-33(19-26-13-15-28(53)16-14-26)42(59)51-17-9-12-34(51)40(57)47-32(39(56)50-36(25(6)52)43(60)61)20-27-21-45-31-11-8-7-10-29(27)31/h7-8,10-11,13-16,21-25,30,32-36,45,52-53H,9,12,17-20,44H2,1-6H3,(H,46,58)(H,47,57)(H,48,54)(H,49,55)(H,50,56)(H,60,61)/t24-,25+,30-,32-,33-,34-,35-,36-/m0/s1
InChIKey
KBSQBKDKTBPPIE-DTSDQQARSA-N
PubChem Compound ID
25054652
Target and Pathway
Target(s) P2X purinoceptor 3 Target Info Inhibitor [528976]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
References
Ref 528976J Med Chem. 2007 Sep 6;50(18):4543-7. Epub 2007 Aug 3.Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.
Ref 528976J Med Chem. 2007 Sep 6;50(18):4543-7. Epub 2007 Aug 3.Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.